Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Do Prevention Programs Save Money? CBO Says 'No'
The Congressional Budget Office has so far "failed to attribute any savings to increased efforts to provide preventive efforts like stop-smoking programs," challenging the notion that preventive care saves money for the health care system, NPR reports. "Former CBO health analyst Joe Antos, now at the American Enterprise Institute, says preventive services often cost more than they save. In screening people for cancer, for example, he says, "you screen literally millions of people, sometimes at fairly high cost per screen. You"ll pick up some true positives, people who really have the disease. You"ll pick up some false positives." Then all those people have to be followed up by the medical system, which costs even more money."
generic viagra online
Measurement Affects Racial Variations In Excessive Daytime Sleepiness
According to a research abstrac presented on Monday, June 8, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, white Americans are more likely to report experiencing excessive daytime sleepiness (EDS) more days per month than Asians, African Americans and Hispanics, but African Americans experience more severe EDS.
News of the day
Novocell Obtains U.S. Patent For Drug Screening Human Embryonic Cell Derived-Endoderm Cells
Novocell, Inc., a stem cell engineering company, announced that it has received U.S. Patent No. 7,541,185 with method claims covering the use of endoderm cells derived from human embryonic stem cells (hESCs) for drug discovery. This is the second U.S. patent issued to Novocell related to human endoderm. U.S. Patent No. 7,510,876, issued on March 31, 2009, is directed to an in vitro human endoderm composition.
Health Insurance

Illumina Launches Multi-Sample Indexing For GoldenGate(R) Assay

Illumina, Inc. (NASDAQ:ILMN) launched GoldenGate Indexing, a high-throughput genotyping solution that utilizes multi-sample indexing technology. Researchers may now screen up to 16 times as many samples per reaction as the standard GoldenGate Assay, increasing throughput from 288 samples per day to greater than 2000, while decreasing total reagent consumption. This high-quality genotyping system includes automation control and positive sample tracking through an Illumina Laboratory Information Management System (LIMS), creating a turnkey solution for low-complexity screening at an affordable cost per sample. The plexity ranges include 96-plex, 192-plex and 384-plex, which are ideal for screening in the livestock and agriculture market as well as for whole-genome association target validation and quality control applications. Livestock geneticists, including Curt Van Tassell of the USDA Agricultural Research Service, worked with Illumina to develop GoldenGate Indexing and are now working on a custom panel for screening livestock. Replacing older methods will allow livestock screening labs to better access genetic information of value. For example, breeders use SNP data to identify DNA markers for applications such as identifying parentage and economically important traits, including disease resistance, marbling, and feed efficiency. With Illumina"s new GoldenGate Indexing, researchers will have a higher degree of multiplexing options at a cost they can afford. "Both livestock and crop researchers have a vested interest in adopting low-plex, high-sample throughput genotyping as a more efficient method for screening. GoldenGate Indexing offers genetic laboratories the opportunity to expand their existing efforts in molecular breeding with a low-cost, fully automated system for fixed and custom content studies," said Joel McComb, senior vice president and general manager of Illumina"s Life Sciences business unit. The Illumina GoldenGate Assay is a flexible, pre-optimized assay providing consistent, high-quality genotyping results. GoldenGate Indexing leverages this proven technology by evolving it into a high-sample throughput solution with fully integrated automation and sample tracking capabilities. GoldenGate Indexing represents only one aspect of Illumina"s broad portfolio of genetic analysis tools for human and agricultural research. Illumina"s array and sequencing-based technologies support the industry"s broadest range of genetic analysis applications. For more information, please visit http://www.illumina.com/goldengateindexing. Illumina


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009